Significant Collaboration Transactions - Additional Information (Details) $ in Thousands		1 Months Ended				3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($) shares	Apr. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($) shares	Mar. 31, 2021 USD ($) shares	Dec. 31, 2019 USD ($) shares	Jun. 30, 2022 USD ($) shares	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) shares	Jun. 30, 2022 USD ($) Obligations shares	Jun. 30, 2021 USD ($)	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($) Obligations shares	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 USD ($) shares
Business Acquisition [Line Items]
Number of additional common units received | shares									7,245,000
Loss on equity method investments | $						$ (10,166)	$ (4,346)		$ (31,053)	$ (32,970)
Deferred revenue | $	$ 146,095					146,095			146,095			$ 160,821
Revenue, Remaining Performance Obligation, Amount | $	53,800					53,800			53,800			$ 21,100
Number of allocated performance obligations | Obligations												10
Arcaea [Member]
Business Acquisition [Line Items]
Consideration | $												$ 35,500
Additional share | shares												5,229,900
Number of common units received | shares				1,755,000
Additional preferred units issued | shares												5,229,900
Allonnia [Member]
Business Acquisition [Line Items]
Consideration | $													$ 18,500
Number of common units received | shares											3,600,000
Number of additional common units received | shares								1,867,411
Carrying value of the equity method investment | $									0			$ 0		$ 24,500
Loss on equity method investments | $								$ (12,700)						$ (24,500)
Allocated upfront non-cash consideration | $									2,500
Deferred revenue | $	$ 35,900					35,900			35,900			38,000
Deferred revenue, Revenue recognized | $						$ 400	1,100		$ 3,700	3,400
Additional non-cash consideration | $								12,700
Number of allocated performance obligations | Obligations									10
Fixed non-cash consideration | $									$ 2,500
Arcaea LLC [Member]
Business Acquisition [Line Items]
Common units | shares	731,250					731,250			731,250
Carrying value of the equity method investment | $				$ 11,900
carrying value outstanding | $				$ 0				0
Loss on equity method investments | $								$ (11,900)
Allocated upfront non-cash consideration | $									$ 1,200
Deferred revenue | $	$ 43,800					$ 43,800			43,800			47,400
Deferred revenue, Revenue recognized | $						2,400	$ 1,200		6,300	$ 1,200
Additional non-cash consideration | $												35,500
Revenue, Remaining Performance Obligation, Amount | $												$ 3,600
BiomEdit LLC [Member]
Business Acquisition [Line Items]
Consideration | $		$ 32,500
Common units | shares		3,900,000
Shares Forfeited | shares		731,250
Carrying value of the equity method investment | $	$ 4,300	$ 8,900
Loss on equity method investments | $						$ 4,600
Allocated upfront non-cash consideration | $									$ 2,200
License [Member] | Arcaea LLC [Member]
Business Acquisition [Line Items]
Common units | shares				9,000,000				9,000,000
License [Member] | Ayana Bio LLC [Member]
Business Acquisition [Line Items]
Common units | shares												9,000,000
Series A Preferred Stock
Business Acquisition [Line Items]
Consideration | $				$ 19,500								$ 57,100
Share Sold | shares				1,755,000
Additional share | shares				7,245,000	5,400,000
Number of additional common units received | shares											1,867,411
Additional preferred units issued | shares				7,245,000	5,400,000
Series A Preferred Stock | Arcaea [Member]
Business Acquisition [Line Items]
Business Combination, Issue | shares												5,139,900
Number of additional common units received | shares												5,229,900
Series A Preferred Stock | Allonnia [Member]
Business Acquisition [Line Items]
Consideration | $					$ 33,000						$ 200
Share Sold | shares													1,664,911	2,970,000
Additional share | shares					630,000
Business Combination, Issue | shares			22,500
Additional preferred units issued | shares					5,400,000								1,844,911	5,400,000
Additional preferred units issued | shares					630,000
Share issued In Exchange For The Rights To Certain Intellectual Property | shares													180,000
Series A Preferred Stock | Ayana Bio LLC [Member]
Business Acquisition [Line Items]
Consideration | $			$ 30,000
Share Sold | shares			9,000,000
Series A Preferred Stock | BiomEdit LLC [Member]
Business Acquisition [Line Items]
Share Sold | shares		6,662,500
Additional share | shares		1,537,500
Additional preferred units issued | shares		1,537,500